Noboru Taniguchi

Prof. Noboru Taniguchi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2017 in Human Cell
Verified
Journal Article
Closed access
PDF file
NTNoboru Taniguchi
Noboru Taniguchi
YKYasuhiko Kawakami
Yasuhiko Kawakami
IMIkuro Maruyama
Ikuro Maruyama
MLMartin Lotz
Martin Lotz

1 June 2015 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
NTNoboru Taniguchi
Noboru Taniguchi
NSNaoki Suenaga
Naoki Suenaga
NONaomi Oizumi
Naomi Oizumi
NMNaoki Miyoshi
Naoki Miyoshi
HYHiroshi Yamaguchi
Hiroshi Yamaguchi
ECEtsuo Chosa
Etsuo Chosa

3 December 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
HSHiromi Sasaki
Hiromi Sasaki
SNSatoshi Nagano
Satoshi Nagano
NTNoboru Taniguchi
Noboru Taniguchi
TSTakao Setoguchi
Takao Setoguchi
Malignant soft-tissue sarcoma resection is associated with a relatively high incidence of surgical site infection (SSI). The known risk factors for SSI following soft-tissue sarcoma resection include tumor size and location, prolonged surgery, and massive blood loss. The geriatric nutritional risk index (GNRI) was used as a tool to help predict the occurrence of SSI after major surgery. We investigated the utility of the GNRI as a predictor of SSI following soft-tissue sarcoma resection. We retrospectively reviewed 152 patients who underwent surgical resection of soft-tissue sarcoma in our institute, and found that the incidence of SSI was 18.4% (28/152). The SSI and non-SSI groups significantly differed regarding surgical time, diameter of the skin incision, maximum tumor diameter, instrumentation, presence of an open wound, preoperative chemotherapy, preoperative C-reactive protein concentration, and GNRI. Binomial logistic regression analysis showed that the risk factors for SSI following soft-tissue sarcoma surgery were male sex, larger skin incision diameter, larger maximum tumor diameter, presence of an open wound, and lower GNRI. Our findings indicate that malnutrition is a risk factor for SSI after soft-tissue sarcoma resection, and suggest that appropriate assessment and intervention for malnutrition may reduce the incidence of SSI.

1 May 2014 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
NTNoboru Taniguchi
Noboru Taniguchi
NSNaoki Suenaga
Naoki Suenaga
NONaomi Oizumi
Naomi Oizumi
NMNaoki Miyoshi
Naoki Miyoshi
NANoriya Araki
Noriya Araki
ECEtsuo Chosa
Etsuo Chosa

30 December 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CBCostansia Bureta
Costansia Bureta
TSTakao Setoguchi
Takao Setoguchi
YSYoshinobu Saitoh
Yoshinobu Saitoh
HTHiroyuki Tominaga
Hiroyuki Tominaga
SMShingo Maeda
Shingo Maeda
NTNoboru Taniguchi
Noboru Taniguchi
The activation and proliferation of microglia is characteristic of the early stages of brain pathologies. In this study, we aimed to identify a factor that promotes microglial activation and proliferation and examined the in vitro effects on these processes. We cultured microglial cell lines, EOC 2 and SIM-A9, with various growth factors and evaluated cell proliferation, death, and viability. The results showed that only transforming growth factor beta (TGF-β) caused an increase in the in vitro proliferation of both microglial cell lines. It has been reported that colony-stimulating factor 1 promotes the proliferation of microglia, while TGF-β promotes both proliferation and inhibition of cell death of microglia. However, upon comparing the most effective doses of both (assessed from the proliferation assay), we identified no statistically significant difference between the two factors in terms of cell death; thus, both have a proliferative effect on microglial cells. In addition, a TGF-β receptor 1 inhibitor, galunisertib, caused marked inhibition of proliferation in a dose-dependent manner, indicating that inhibition of TGF-β signalling reduces the proliferation of microglia. Therefore, galunisertib may represent a promising therapeutic agent for the treatment of neurodegenerative diseases via inhibition of nerve injury-induced microglial proliferation, which may result in reduced inflammatory and neuropathic and cancer pain.

13 June 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
HSHiromi Sasaki
Hiromi Sasaki
SNSatoshi Nagano
Satoshi Nagano
SKSetsuro Komiya
Setsuro Komiya
NTNoboru Taniguchi
Noboru Taniguchi
TSTakao Setoguchi
Takao Setoguchi
Predicting outcomes in patients with soft tissue sarcoma (STS) is challenging. To improve these predictions, we retrospectively analyzed common nutritional assessment systems, including Glasgow prognostic score (GPS), Geriatric Nutritional Risk Index (GNRI), neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), and controlling nutritional (CONUT) score against outcomes in 103 patients with STS, of whom 15 (14.6%) died within 1 year of diagnosis. GPS, GNRI, NLR, PLR, and CONUT scores significantly differed between patients who died within one year and patients who lived longer. Binomial logistic regression analysis showed that male sex, older age at diagnosis, higher GPS, higher stage, and unresectable STS were risk factors for death within a year of diagnosis. Overall survival was evaluated by Cox proportional hazards models, which correlated higher NLR, higher PLR, larger maximum diameter of tumor, higher stage, and unresectable STS with poor prognosis. We next examined prognostic factors in the 93 patients with resectable STS, and found male sex, higher GPS, and higher stage were correlated with poor prognosis in these patients. Our findings suggest that GPS, NLR, and PLR are simple predictors of outcome in patients with STS. Nutritional therapies might improve their GPS and prognosis.